Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Authorized    symbols : GILD    save search
FDA Grants Marketing Authorization to Siemens Healthineers ELF Test for NASH Prognostic Assessment
Published: 2021-08-24 (Crawled : 18:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | | O: 0.11% H: 0.08% C: -0.52%
fda test nash authorized granted grant
European Medicines Agency Validates Gilead’s Marketing Authorization Application for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options
Published: 2021-08-19 (Crawled : 23:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | | O: -0.49% H: 1.01% C: 0.08%
treatment europe therapy hiv authorized xin
Roche’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
Published: 2021-06-25 (Crawled : 07:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | | O: -0.06% H: 1.28% C: 1.1%
covid treatment fda children merge authorized emergency use authorization
Gainers vs Losers
67% 33%

Top 10 Gainers
JOE 4 | $54.88 1.22% 0.22% 210K twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.